Fortress Biotech Inc expected to post a loss of 36 cents a share - Earnings Preview

Fortress Biotech

08/08/2025 13:41

Fortress Biotech Inc FBIO.OQ FBIO.O is expected to  show a fall in quarterly revenue when it reports  results on August 11 (estimated) for the period ending June 30 2025

The Bay Harbor Islands Florida-based  company is expected to report a 2.4% decrease in revenue to $14.534 million from $14.9 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Fortress Biotech Inc is for a loss of 36 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Fortress Biotech Inc is $16.00, about 88.4% above its last closing price of $1.85

This summary was machine generated August 8 at 12:41 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)